Onset after SLE diagnosis | Frequency (%) | |||||||
1–5 years post-SLE diagnosis | 29 (35.4) | |||||||
6–10 years post-SLE diagnosis | 12 (14.6%) | |||||||
>10 years post-SLE diagnosis | 41 (50.0%) | |||||||
HZ symptoms: occurrence of pain, itching, tingling with rash | ||||||||
No | 4 (4.9%) | |||||||
Yes | 78 (95.1%) | |||||||
Confirmed of HZ diagnosis by physician | ||||||||
No | 1 (1.2%) | |||||||
Yes | 81 (98.8%) | |||||||
Vaccination history: ever received varicella zoster vaccine | ||||||||
No | 69 (84.2%) | |||||||
Yes | 13 (15.9%) | |||||||
Hospitalisations: ever hospitalised for severe HZ? | ||||||||
No | 69 (84.2%) | |||||||
Yes | 13 (15.9%) | |||||||
Treatment for HZ : ever received treatments (eg, antivirals) for HZ? | ||||||||
No | 16 (20%) | |||||||
Yes | 64 (80%) | |||||||
Missing | 2 | |||||||
Postherpetic neuralgia: history of severe pain after HZ infection? | ||||||||
No | 35 (44.3%) | |||||||
Yes | 44 (55.7%) | |||||||
Missing | 3 | |||||||
Duration of postherpetic neuralgia, if present | ||||||||
3 months | 20 (48.8%) | |||||||
3–6 months | 7 (17.1%) | |||||||
>6 months | 14 (34.2%) | |||||||
Missing | 3 | |||||||
SLE treatments at time of HZ infection? | ||||||||
Prednisone | 59 (71.9%) | |||||||
Hydroxychloroquine | 50 (61%) | |||||||
Azathioprine | 29 (35%) | |||||||
Mycophenolate mofetil or mycophenolic acid | 14 (17.1%) | |||||||
Cyclophosphamide | 2 (2.4%) | |||||||
Belimumab | 0 (0%) | |||||||
Rituximab | 2 (2.4%) | |||||||
Methotrexate | 4 (4.9%) | |||||||
Other treatment | 15 (18.3%) | |||||||
Prednisone dose in mg/day, if taken | ||||||||
Frequency | Missing | Minimum dose | Mean dose | SD | Median dose | Lower quartile | Upper quartile | Maximum dose |
23 | 36 | 1 | 22.3 | 19.5 | 15 | 5 | 30 | 60 |
HZ, herpes zoster.